Coding Ahead
CasePilot
Medical Coding Assistant
Case2Code
Search and Code Lookup Tool
CareerCenter
Medical Coding Job Board
Log in Register free account

Need help choosing the right code?

Ask CasePilot about procedures, modifiers, bundling, and coding guidance.

Try CasePilot

Official Description

Pneumococcal conjugate vaccine, 7 valent (PCV7), for intramuscular use

© Copyright 2026 American Medical Association. All rights reserved.

Common Language Description

The CPT® Code 90669 refers to the pneumococcal conjugate vaccine, specifically the 7 valent formulation (PCV7), which is intended for intramuscular use. Vaccines, such as this pneumococcal conjugate vaccine, are designed to provide active, long-term immunity by stimulating the recipient's immune system. This is achieved by introducing altered versions of specific bacteria, which in this case are the pneumococcal bacteria. When administered, the vaccine prompts the immune system to produce its own antibodies against these bacteria, enabling the body to recognize and respond more effectively upon future exposure to the actual pathogens. Pneumococcal bacteria are commonly found in the nasal passages and throats of many individuals without causing any illness. However, if these bacteria invade the body, they can lead to serious health conditions such as pneumococcal pneumonia, bacteremia, and meningitis. Certain populations, including children under the age of 5, the elderly, and individuals with compromised immune systems, are particularly vulnerable to these infections. The 7 valent vaccine specifically targets seven distinct serotypes of the pneumococcal bacterium, which are designated as 4, 6B, 9V, 14, 18C, 19F, and 23F. It is important to note that this vaccine is administered via a separately reportable intramuscular injection. For broader coverage, the 13 valent vaccine (CPT® Code 90670) includes the same seven serotypes as well as six additional serotypes, expanding the protective benefits against pneumococcal disease.

© Copyright 2026 Coding Ahead. All rights reserved.

1. Indications

The pneumococcal conjugate vaccine, 7 valent (PCV7), is indicated for the prevention of pneumococcal disease caused by specific serotypes of the pneumococcal bacterium. The following populations are particularly recommended to receive this vaccine:

  • Children under 5 years of age - This group is at a higher risk for severe pneumococcal infections, including pneumonia and meningitis.
  • The elderly - Older adults often have weakened immune systems, making them more susceptible to pneumococcal diseases.
  • Individuals with compromised immune systems - Those who are immunosuppressed due to medical conditions or treatments are at increased risk for infections.

2. Procedure

The administration of the pneumococcal conjugate vaccine, 7 valent (PCV7), involves the following procedural steps:

  • Step 1: Preparation - Prior to administration, the healthcare provider should ensure that the vaccine is stored correctly and is at the appropriate temperature. The provider must also review the patient's medical history to confirm that the individual is eligible for vaccination and to check for any contraindications.
  • Step 2: Injection Site Selection - The vaccine is administered via intramuscular injection, typically in the deltoid muscle of the upper arm for older children and adults, or in the anterolateral thigh for infants and young children.
  • Step 3: Administration - The healthcare provider will clean the injection site with an antiseptic wipe, allow it to dry, and then inject the vaccine using a sterile syringe and needle. The injection should be given at a 90-degree angle to ensure proper delivery into the muscle.
  • Step 4: Post-Administration Care - After the injection, the provider should observe the patient for a brief period to monitor for any immediate adverse reactions. The patient may be given information on potential side effects and the importance of follow-up vaccinations if applicable.

3. Post-Procedure

Post-procedure care for the pneumococcal conjugate vaccine, 7 valent (PCV7), includes monitoring the patient for any immediate adverse reactions, such as allergic responses or injection site reactions. Patients may experience mild side effects, including soreness at the injection site, low-grade fever, or irritability, which typically resolve on their own. It is important for healthcare providers to educate patients and caregivers about these potential side effects and to advise them on when to seek further medical attention. Additionally, documentation of the vaccine administration, including the date, lot number, and site of injection, should be recorded in the patient's medical record to ensure proper tracking of immunizations.

Short Descr PCV7 VACCINE IM
Medium Descr PCV7 VACCINE FOR INTRAMUSCULAR USE
Long Descr Pneumococcal conjugate vaccine, 7 valent (PCV7), for intramuscular use
Related Drugs PREVNAR
Status Code Statutory Exclusion (from MPFS, may be paid under other methodologies)
Global Days XXX - Global Concept Does Not Apply
PC/TC Indicator (26, TC) 9 - Not Applicable
Multiple Procedures (51) 9 - Concept does not apply.
Bilateral Surgery (50) 9 - Concept does not apply.
Physician Supervisions 09 - Concept does not apply.
Assistant Surgeon (80, 82) 9 - Concept does not apply.
Co-Surgeons (62) 9 - Concept does not apply.
Team Surgery (66) 9 - Concept does not apply.
Diagnostic Imaging Family 99 - Concept Does Not Apply
APC Status Indicator Influenza, Pneumococcal Pneumonia, Hepatitis B, and Covid-19 Vaccines; Monoclonal Antibody Therapy Product
Type of Service (TOS) V - Pneumococcal/Flu Vaccine
Berenson-Eggers TOS (BETOS) O1G - Immunizations/Vaccinations
MUE Not applicable/unspecified.
CCS Clinical Classification 228 - Prophylactic vaccinations and inoculations
Date
Action
Notes
2016-01-01 Changed First appearance of change in codebook.
2016-01-01 Deleted Deleted
2015-07-01 Changed Description Changed.
2011-01-01 Changed Short description changed.
2010-01-01 Changed Code description changed.
2007-01-01 Changed Code description changed.
2005-01-01 Changed Code description changed.
2001-01-01 Changed Code description changed.
1999-01-01 Added First appearance in code book in 1999.
Code
Description
Code
Description
Code
Description
Code
Description
CasePilot

Get instant expert-level medical coding assistance.

Ask about:
CPT Codes Guidelines Modifiers Crosswalks NCCI Edits Compliance Medicare Coverage
Example: "What is CPT code 99213?" or "Guidelines for E/M services"